Biomembrane-wrapped gene delivery nanoparticles for cancer therapy

As a promising strategy, gene delivery for cancer treatment accepts encouraging progress due to its high efficacy, low toxicity, and exclusive selectivity. However, the delivery efficiency, specific biological distribution, targeted uptake, and biosafety of naked nucleic acid agents still face serious challenges, which limit further clinical application. To overcome the above bottleneck, safe and efficient functional nanovectors are developed to improve the delivery efficiency of nucleic acid agents. In recent years, emerging membrane-wrapped biomimetic nanoparticles (MBNPs) based on the concept of “imitating nature” are well known for their advantages, such as low immunogenicity and long cycle time, and especially play a crucial role in improving the overall efficiency of gene delivery and reducing adverse reactions. Therefore, combining MBNPs and gene delivery is an effective strategy to enhance tumor treatment efficiency. This review presents the mechanism of gene therapy and the current obstacles to gene delivery. Remarkably, the latest development of gene delivery MBNPs and the strategies to overcome these obstacles are summarized. Finally, the future challenges and prospects of gene delivery MBNPs toward clinical transformation are introduced. The principal purpose of this review is to discuss the biomedical potential of gene delivery MBNPs for cancer therapy and to provide guidance for further enhancing the efficiency of tumor gene therapy.

[1]  K. Toh,et al.  Stealth and pseudo-stealth nanocarriers. , 2023, Advanced drug delivery reviews.

[2]  Huaqiang Fang,et al.  Biomimetic Biomembrane Encapsulation and Targeted Delivery of a Nitric Oxide Release Platform for Therapy of Parkinson's Disease. , 2023, ACS biomaterials science & engineering.

[3]  Zhigang Wang,et al.  Anti-CXCR2 antibody-coated nanoparticles with an erythrocyte-platelet hybrid membrane layer for atherosclerosis therapy. , 2023, Journal of controlled release : official journal of the Controlled Release Society.

[4]  J. Wang,et al.  Preparation of an amphiphilic peptide (P13) with proton sponge effect and analysis of its antitumor activity , 2023, Nanotechnology.

[5]  Xin Huang,et al.  Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy. , 2023, Drug discovery today.

[6]  Jian-qiao Hong,et al.  Therapeutic potential and mechanisms of mesenchymal stem cell-derived exosomes as bioactive materials in tendon–bone healing , 2023, Journal of Nanobiotechnology.

[7]  Yinhong Song,et al.  Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis , 2023, Journal of Nanobiotechnology.

[8]  Xin Huang,et al.  Macrophage membrane-coated nanovesicles for dual-targeted drug delivery to inhibit tumor and induce macrophage polarization , 2022, Bioactive materials.

[9]  Xie Shanshan,et al.  Editorial: The role of the IGF axis in tumorigenesis and cancer treatment: From genes to metabolites , 2023, Frontiers in Endocrinology.

[10]  Jiesi Luo,et al.  Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment , 2022, Journal of Nanobiotechnology.

[11]  J. Lin,et al.  Biocompatible Assessment of Erythrocyte Membrane-Camouflaged Polymeric PLGA Nanoparticles in Pregnant Mice: Both on Maternal and Fetal/Juvenile Mice , 2022, International journal of nanomedicine.

[12]  M. Coathup,et al.  Macromolecules Absorbed from Influenza Infection-Based Sera Modulate the Cellular Uptake of Polymeric Nanoparticles , 2022, Biomimetics.

[13]  Jianqing Gao,et al.  Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system , 2022, Drug Delivery and Translational Research.

[14]  J. Xu,et al.  Erythrocyte membrane camouflaged siRNA/chemodrug nanoassemblies for cancer combination therapy. , 2022, Biomaterials science.

[15]  Qiqi Zhang,et al.  The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy , 2022, Molecular Cancer.

[16]  E. S. Day,et al.  Membrane-Wrapped Nanoparticles for Enhanced Chemotherapy of Acute Myeloid Leukemia. , 2022, ACS biomaterials science & engineering.

[17]  Gangfeng Ouyang,et al.  An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy. , 2022, Acta biomaterialia.

[18]  Yongxin Li,et al.  Stochastic Collision Electrochemistry from Single Pt Nanoparticles: Electrocatalytic Amplification and MicroRNA Sensing. , 2022, Analytical chemistry.

[19]  Wenlin An,et al.  Biomimetic Exosomes: A New Generation of Drug Delivery System , 2022, Frontiers in Bioengineering and Biotechnology.

[20]  Changhai Ding,et al.  Enhanced osteoarthritis therapy by nanoengineered mesenchymal stem cells using biomimetic CuS nanoparticles loaded with plasmid DNA encoding TGF-β1 , 2022, Bioactive materials.

[21]  S. Rutz,et al.  High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA , 2022, The Journal of experimental medicine.

[22]  Liang Han,et al.  Biomimetic Lipopolysaccharide‐Free Bacterial Outer Membrane‐Functionalized Nanoparticles for Brain‐Targeted Drug Delivery , 2022, Advanced science.

[23]  Xiaotu Ma,et al.  Rapid Surface Display of mRNA Antigens by Bacteria‐Derived Outer Membrane Vesicles for a Personalized Tumor Vaccine , 2022, Advanced materials.

[24]  D. Berti,et al.  Interaction of Metallic Nanoparticles With Biomimetic Lipid Liquid Crystalline Cubic Interfaces , 2022, Frontiers in Bioengineering and Biotechnology.

[25]  Yong Gan,et al.  Tumour‐derived extracellular vesicle membrane hybrid lipid nanovesicles enhance siRNA delivery by tumour‐homing and intracellular freeway transportation , 2022, Journal of extracellular vesicles.

[26]  T. Sharp,et al.  Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System , 2022, Advanced materials.

[27]  I. Ng,et al.  Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer , 2022, Nature communications.

[28]  Ying Chen,et al.  Development of a Dendritic Cell/Tumor Cell Fusion Cell Membrane Nano-Vaccine for the Treatment of Ovarian Cancer , 2022, Frontiers in Immunology.

[29]  Tao Zhang,et al.  Biomimetic Nanoerythrosome‐Coated Aptamer–DNA Tetrahedron/Maytansine Conjugates: pH‐Responsive and Targeted Cytotoxicity for HER2‐Positive Breast Cancer , 2022, Advanced materials.

[30]  Jiancheng Wang,et al.  Non-viral vectors for RNA delivery , 2022, Journal of Controlled Release.

[31]  E. Kipreos,et al.  Emerging roles for folate receptor FOLR1 in signaling and cancer , 2022, Trends in Endocrinology & Metabolism.

[32]  Z. Shao,et al.  Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Yang Yang,et al.  Macrophage membrane- and cRGD-functionalized thermosensitive liposomes combined with CPP to realize precise siRNA delivery into tumor cells , 2021, Molecular therapy. Nucleic acids.

[34]  A. Johnston,et al.  Quantifying the Endosomal Escape of pH-Responsive Nanoparticles Using the Split Luciferase Endosomal Escape Quantification Assay. , 2021, ACS applied materials & interfaces.

[35]  Lei Xing,et al.  Enhanced nuclear gene delivery via integrating and streamlining intracellular pathway. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Ping Wang,et al.  Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy , 2021, Frontiers in Oncology.

[37]  S. D. De Smedt,et al.  Pulmonary surfactant as a versatile biomaterial to fight COVID-19 , 2021, Journal of Controlled Release.

[38]  Wei Zhang,et al.  Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer , 2021, Journal of Nanobiotechnology.

[39]  S. Ju,et al.  CircRNAs and their regulatory roles in cancers , 2021, Molecular Medicine.

[40]  H. Dai,et al.  Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC , 2021, Journal of Nanobiotechnology.

[41]  Quan P. Ly,et al.  Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis. , 2021, Gastroenterology.

[42]  Minhyung Lee,et al.  Biomimetic cell membrane-coated DNA nanoparticles for gene delivery to glioblastoma. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[43]  Qinjun Chen,et al.  Sequentially Triggered Bacterial Outer Membrane Vesicles for Macrophage Metabolism Modulation and Tumor Metastasis Suppression. , 2021, ACS nano.

[44]  J. Sluijter,et al.  Functional siRNA Delivery by Extracellular Vesicle–Liposome Hybrid Nanoparticles , 2021, Advanced healthcare materials.

[45]  S. Trigueros,et al.  Nanotechnology-Based Strategies to Overcome Current Barriers in Gene Delivery , 2021, International journal of molecular sciences.

[46]  Jing Zhu,et al.  Time-Dependent Internalization of S100B by Mesenchymal Stem Cells via the Pathways of Clathrin- and Lipid Raft-Mediated Endocytosis , 2021, Frontiers in Cell and Developmental Biology.

[47]  W. Miesbach,et al.  Gene Therapy for Hemophilia: a review on clinical benefit, limitations and remaining issues. , 2021, Blood.

[48]  Jiyong Liu,et al.  Hybrid Membrane-Coated Biomimetic Nanoparticles (HM@BNPs): A Multifunctional Nanomaterial for Biomedical Applications. , 2021, Biomacromolecules.

[49]  M. Bissonnette,et al.  CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies , 2021, International journal of molecular sciences.

[50]  R. Ferris,et al.  Epidermal Growth Factor Receptor-Targeted Therapy for Head and Neck Cancer. , 2021, Otolaryngologic clinics of North America.

[51]  Xin Cheng,et al.  Polystyrene nanoplastics exposure caused defective neural tube morphogenesis through caveolae-mediated endocytosis and faulty apoptosis , 2021, Nanotoxicology.

[52]  Chao Liu,et al.  Effect of Extracellular Matrix Coating on Cancer Cell Membrane-Encapsulated Polyethyleneimine/DNA Complexes for Efficient and Targeted DNA Delivery In Vitro. , 2021, Molecular pharmaceutics.

[53]  Da-Hong Gao,et al.  Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and Prospects , 2021, The AAPS Journal.

[54]  Jinlan Jiang,et al.  Doxorubicin and PD-L1 siRNA co-delivery with stem cell membrane-coated polydopamine nanoparticles for the targeted chemoimmunotherapy of PCa bone metastases. , 2021, Nanoscale.

[55]  Xiaofei Liang,et al.  Expression and mechanism of exosome-mediated A FOXM1 related long noncoding RNA in gastric cancer , 2021, Journal of Nanobiotechnology.

[56]  John M. Ashton,et al.  Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy , 2021, Science Advances.

[57]  Howard Y. Chang,et al.  Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing , 2021, Cell.

[58]  R. Pettigrew,et al.  The Limitless Future of RNA Therapeutics , 2021, Frontiers in Bioengineering and Biotechnology.

[59]  M. Penichet,et al.  Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents , 2021, Frontiers in Immunology.

[60]  M. Stevens,et al.  Surfactant Protein B Promotes Cytosolic SiRNA Delivery by Adopting a Virus-like Mechanism of Action. , 2021, ACS nano.

[61]  Ronnie H. Fang,et al.  Nanomaterial Biointerfacing via Mitochondrial Membrane Coating for Targeted Detoxification and Molecular Detection. , 2021, Nano letters.

[62]  Z. Berneman,et al.  The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy , 2021, Pharmaceutics.

[63]  Wei Zhang,et al.  Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles , 2021, Journal of Nanobiotechnology.

[64]  Guy C. Brown,et al.  Microglial phagocytosis of neurons in neurodegeneration, and its regulation , 2021, Journal of neurochemistry.

[65]  F. Aqil,et al.  Exosome-mediated delivery of RNA and DNA for gene therapy. , 2021, Cancer letters.

[66]  Xinlong Liu,et al.  A Virus‐Mimicking Nucleic Acid Nanogel Reprograms Microglia and Macrophages for Glioblastoma Therapy , 2021, Advanced materials.

[67]  D. Větvička,et al.  Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next? , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[68]  E. Rodríguez-Bocanegra,et al.  Immune responses to retinal gene therapy using adeno-associated viral vectors – Implications for treatment success and safety , 2020, Progress in Retinal and Eye Research.

[69]  M. Aepfelbacher,et al.  Cargo-specific recruitment in clathrin and dynamin-independent endocytosis , 2020, bioRxiv.

[70]  T. Ohtsuki,et al.  Photoinduced Endosomal Escape Mechanism: A View from Photochemical Internalization Mediated by CPP-Photosensitizer Conjugates , 2020, Molecules.

[71]  D. Purmessur,et al.  Non-viral Gene Delivery Methods for Bone and Joints , 2020, Frontiers in Bioengineering and Biotechnology.

[72]  G. Muday,et al.  The Role of ROS Homeostasis in ABA-Induced Guard Cell Signaling , 2020, Frontiers in Plant Science.

[73]  Francesca Taraballi,et al.  Cell Membrane-Based Biomimetic Nanoparticles and the Immune System: Immunomodulatory Interactions to Therapeutic Applications , 2020, Frontiers in Bioengineering and Biotechnology.

[74]  K. Toh,et al.  Transient stealth coating of liver sinusoidal wall by anchoring two-armed PEG for retargeting nanomedicines , 2020, Science Advances.

[75]  Hongying Chen,et al.  Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy. , 2020, Acta biomaterialia.

[76]  Weiwei Huang,et al.  Modified bacterial outer membrane vesicles induce autoantibodies for tumor therapy. , 2020, Acta biomaterialia.

[77]  Lufang Ning,et al.  Stability and absorption mechanism of typical plant miRNAs in an in vitro gastrointestinal environment: basis for their cross-kingdom nutritional effects. , 2020, The Journal of nutritional biochemistry.

[78]  Lingmin Zhang,et al.  Homotypic Targeting Delivery of siRNA with Artificial Cancer Cells , 2020, Advanced healthcare materials.

[79]  Ronnie H. Fang,et al.  Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles , 2020, Science Advances.

[80]  B. Lujan,et al.  Retinal gene therapy in X-linked retinitis pigmentosa caused by mutations in RPGR: Results at 6 months in a first in human clinical trial , 2020, Nature Medicine.

[81]  S. Wilhelm,et al.  The entry of nanoparticles into solid tumours , 2020, Nature Materials.

[82]  Y. Ba,et al.  Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer , 2020, Molecular oncology.

[83]  Weimin Cai,et al.  SREBP1 siRNA enhance the docetaxel effect based on a bone-cancer dual-targeting biomimetic nanosystem against bone metastatic castration-resistant prostate cancer , 2020, Theranostics.

[84]  B. Larijani,et al.  The Horizon of Gene Therapy in Modern Medicine: Advances and Challenges. , 2019, Advances in experimental medicine and biology.

[85]  Hongyan Zhu,et al.  Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[86]  M. Manoharan,et al.  The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs , 2019, Nature Nanotechnology.

[87]  S. Baldari,et al.  Extracellular Vesicles–Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation , 2019, Cells.

[88]  Y. Yoshioka,et al.  Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[89]  Genxi Li,et al.  Erythrocyte membrane-biointerfaced spherical nucleic acids: Robust performance for microRNA quantification. , 2019, Analytica chimica acta.

[90]  Huan Meng,et al.  Transcytosis - An effective targeting strategy that is complementary to “EPR effect” for pancreatic cancer nano drug delivery , 2019, Theranostics.

[91]  Gareth R. Williams,et al.  Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery , 2019, Journal of Nanobiotechnology.

[92]  Ming Chen,et al.  Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA , 2019, Artificial cells, nanomedicine, and biotechnology.

[93]  Jiansong Ji,et al.  CRISPR-Cas9 for cancer therapy: Opportunities and challenges. , 2019, Cancer letters.

[94]  Jinlan Jiang,et al.  siRNA Delivery with Stem Cell Membrane-Coated Magnetic Nanoparticles for Imaging-Guided Photothermal Therapy and Gene Therapy. , 2018, ACS biomaterials science & engineering.

[95]  Ronnie H. Fang,et al.  Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization , 2017, Advanced materials.

[96]  D. Zheng,et al.  Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell Membranes. , 2016, Nano letters.

[97]  Ronnie H. Fang,et al.  Nanoparticle biointerfacing via platelet membrane cloaking , 2015, Nature.

[98]  K. Toh,et al.  Ternary polyplex micelles with PEG shells and intermediate barrier to complexed DNA cores for efficient systemic gene delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[99]  K. Kataoka,et al.  Optimized rod length of polyplex micelles for maximizing transfection efficiency and their performance in systemic gene therapy against stroma-rich pancreatic tumors. , 2014, Biomaterials.

[100]  Dennis E Discher,et al.  Minimal " Self " Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles References and Notes , 2022 .

[101]  Anne L. van de Ven,et al.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.

[102]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[103]  F. Liu,et al.  Mechanism of naked DNA clearance after intravenous injection , 2007, The journal of gene medicine.